Stocktoria
Dare Bioscience, Inc. DARE
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-04-10
Dare Bioscience, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -1315.5% | -239692.2% | -1101.9% | -313.9% | — | — | — | — | — | -82.3% |
| Net margin | -1300.7% | -41430.9% | -1074.2% | -309.5% | — | — | — | — | — | -87.8% |
| FCF margin | -998.4% | 50087.0% | -1407.8% | -181.6% | — | — | — | — | — | -118.4% |
| Return on assets | -41.3% | -18.3% | -141.7% | -70.6% | -69.3% | -362.9% | -191.6% | -213.8% | -80.7% | -1507.8% |
| Return on equity | -471.4% | 67.4% | 597.5% | -278.5% | -99.8% | 2379.1% | -3235.7% | -248.8% | -86.5% | 94.7% |
| Current ratio | 1.14 | 0.85 | 0.86 | 1.36 | 3.44 | 0.91 | 1.15 | 6.64 | 8.64 | 0.06 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.